Bausch Health Files 8-K
Ticker: BHC · Form: 8-K · Filed: Sep 11, 2025 · CIK: 885590
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-statements
TL;DR
Bausch Health filed an 8-K on 9/11/25. Standard reporting.
AI Summary
Bausch Health Companies Inc. filed an 8-K on September 11, 2025, reporting other events and financial statements. The company, formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp, is incorporated in British Columbia, Canada, and headquartered in Laval, Quebec.
Why It Matters
This filing indicates routine corporate reporting, including financial statements and other events, which is standard for publicly traded companies and provides transparency to investors.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain any significant new risks or material changes.
Key Numbers
- 001-14956 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-0448205 — I.R.S. Employer Identification Number (Tax identification number for the company.)
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
- September 11, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' reported, only that this item is included in the filing.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that updated financial information and supporting documents are being provided to the SEC and the public.
When was Bausch Health Companies Inc. previously known as Valeant Pharmaceuticals International, Inc.?
The company changed its name from Valeant Pharmaceuticals International, Inc. on September 28, 2010.
Where is Bausch Health Companies Inc. incorporated?
Bausch Health Companies Inc. is incorporated in British Columbia, Canada.
What is the primary business classification for Bausch Health Companies Inc.?
The company's Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Stats: 833 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2025-09-11 09:52:05
Key Financial Figures
- $1.75 — mon stock of DURECT ("Shares"), for (a) $1.75 per Share in cash, plus (b) one non-tra
- $350,000,000 — tion of two milestone payments of up to $350,000,000 in the aggregate (net of retention bonu
Filing Documents
- d934691d8k.htm (8-K) — 26KB
- 0001193125-25-200869.txt ( ) — 137KB
- bhc-20250911.xsd (EX-101.SCH) — 2KB
- bhc-20250911_lab.xml (EX-101.LAB) — 17KB
- bhc-20250911_pre.xml (EX-101.PRE) — 11KB
- d934691d8k_htm.xml (XML) — 4KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BAUSCH HEALTH COMPANIES INC. By: /s/ Jean-Jacques Charhon Name: Jean-Jacques Charhon Title: Executive Vice President, Chief Financial Officer Date: September 11, 2025